SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-016486
Filing Date
2023-05-08
Accepted
2023-05-08 17:11:08
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sgmo-20230331.htm   iXBRL 10-Q 1286691
2 EX-31.1 sgmo-20230331xex311.htm EX-31.1 10119
3 EX-31.2 sgmo-20230331xex312.htm EX-31.2 10234
4 EX-32.1 sgmo-20230331xex321.htm EX-32.1 7192
  Complete submission text file 0001628280-23-016486.txt   6357345

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20230331.xsd EX-101.SCH 45772
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20230331_cal.xml EX-101.CAL 60534
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20230331_def.xml EX-101.DEF 244034
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20230331_lab.xml EX-101.LAB 486409
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20230331_pre.xml EX-101.PRE 347361
53 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20230331_htm.xml XML 1109981
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 23898851
SIC: 2836 Biological Products, (No Diagnostic Substances)